Perrigo | PRGO - 销售成本

金融业

USD 15.37

USD 7.61B

现金及等价物

USD 357.2M

USD 708.9M

USD 2.45B

USD 1.05B

USD 3.63B

股息收益率

12.17

USD 33.6M

USD 141.6M

8.38K

EPS每股收益

USD 0.5

股本和储备

USD 2.52B

USD 313.9M

债务利息支出

USD 7.61B

USD 3.28B

USD 2.08B

USD 74.5M

USD 290.5M

USD 23.5M

普通股股本

USD 138.1M

27.45

USD 105.4M

USD 1.02B

销售和管理费用

USD 3.28B

USD 1.06B

贸易债权人

USD 400.4M

应收帐款人

USD 697.1M

	销售成本	更改		日
AbbVie	USD 4.29B		73M	2026-06
Abbott	USD 5.94B		642M	2026-06
Bayer	EUR 4.54B		692M	2026-06
Bristol-Myers Squibb	USD 7.89B		4.03B	2026-06
Coherus Biosciences	USD 4.04M		324K	2025-12
Corcept Therapeutics	USD 4.06M		1.18M	2026-06
Dr.Reddys Laboratories	INR 39.22B		1.52B	2026-06
Eli Lilly	USD 3.27B		309M	2026-06
J&J	USD 8.08B		80M	2026-09
Merck	USD 3.14B		200M	2026-06
Nestle	CHF 23.12B		1.97B	2026-06
Pacira	USD 58.49M		7.75M	2026-06
Perrigo	USD 708.9M		65.2M	2026-06
Pfizer	USD 4.09B		498M	2026-06
Phibro Animal Health	USD 240.42M		2.58M	2025-12
Prestige Brands	USD 135.22M		5.54M	2026-06
Reckitt Benckiser	GBP 2.75B		1.34B	2024-12
Sanofi	EUR 3.02B		656M	2026-06
Supernus Pharmaceuticals	USD 59M		9.97M	2026-06
Teva Pharmaceutical Industries	USD 1.98B		30M	2026-06
Xeris Pharmaceuticals	USD 10.57M		3.08M	2026-03
Zoetis	USD 704M		32M	2026-06